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ABSTRACT: Reference equations for ventilatory function that use different statistical
models may introduce artifacts that affect the estimated change of lung function during
growth in young subjects. The effect of differently modelled reference equations on the
estimated annual change of forced expiratory volume in one second (FEV1) and forced
vital capacity (FVC) in young patients with chronic lung disease was assessed.
Four frequently used reference equations were used to describe the longitudinal
changes of FEV1 and FVC in 52 patients (23 females) with cystic fibrosis (CF) during a
mean follow-up of 3.9 yrs.
Choice of reference equations directly affected value and, most importantly,
estimated annual change of FVC and FEV1. Mean¡SD annual change of FEV1 varied
from 2.2¡6.2 to -2.2¡3.6% of predicted. For two reference equations the estimated
individual changes of FEV1 and FVC in CF were positively correlated with mean
individual age. This probably reflects underestimation of deteriorating lung function.
Variability of annual change was independent of age only when reference equations
that were designed to accurately predict lung function during the pubertal growth spurt
were used. These findings have implications for patient care and clinical research.
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Medium- or long-term follow-up of ventilatory
function in children and adolescents requires a cor-
rection for lung growth. This correction is not only
crucial for monitoring patients with chronic lung
disease and to evaluate individual therapeutic inter-
ventions, but is also important in longitudinal clinical
trials where indices such as forced expiratory volume
in one second (FEV1) and forced vital capacity (FVC)
are often primary end-points. Correction for lung
growth is usually achieved by expressing lung function
parameters as a percentage of predicted (% pred),
although predictions derived from cross-sectional
studies may not accurately reflect lung growth
within an individual [1, 2].
In most pulmonary function reference equations for
growing children, standing height is used as a proxy
for lung growth. Power functions, exponential func-
tions, and linear functions are used to describe the
relationship between standing height and pulmonary
function indices [3]. Though explained variance using
these equations is high, it has been demonstrated that
during the pubertal growth spurt these equations do
not describe the development of pulmonary function
accurately [4–6]. Because of the phase shift in somatic
growth and lung growth, ventilatory function appears
to lag behind during the peak of somatic (leg) growth.
This can result in overestimation of ventilatory
function before and after the growth spurt, and in
underestimation of ventilatory function during the
growth spurt when expressed as % pred. Therefore,
including age as an additional independent variable in
the reference equations would theoretically improve
the validity of the prediction, and such reference equa-
tions have been developed based on large numbers
of children and adolescents from a general popula-
tion [4, 6]. However, the implications of this issue
for patient care, or for long-term clinical trials in
teenagers with chronic lung disease have not been
evaluated extensively. In a recent study [7] it was
demonstrated that the rate of decline of FEV1 in cystic
fibrosis (CF) patients varied according to each one
out of four American reference equations. FEV1 may
be the most robust test of airway function, but if
correction for lung growth is unreliable, this test is
of limited value when studied longitudinally. Accu-
rate correction of ventilatory function for growth
is especially important in children and adolescents
with chronic lung disease. In this study, the effect of
various reference equations [4, 6, 8, 9], that used
different models, and lung-function data of European
and American children and adolescents, on the esti-
mated long-term change of FEV1 and FVC in Dutch
children and adolescents with CF was assessed. Some
of these equations have been used previously in
important clinical trials for patients with asthma [10]
and in patients with CF [11, 12]. The hypothesis was
that the choice of reference equations would have a
considerable effect on the estimated change of FEV1
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and FVC in children and adolescents with chronic
lung disease even though their growth spurt is usually
delayed and reduced [13, 14].
Materials and methods
Data set
The data set consisted of measurements of FEV1
and FVC derived from maximal expiratory flow/
volume curves obtained from all children and ado-
lescents with CF who attended the outpatient clinic
for respiratory medicine between 1994–1999. These
measurements were carried out during annual elective
measurements, when children were clinically stable.
Procedures were carried out using a Lilly-type heated
pneumotachograph (Jaeger, Wu¨rzburg, Germany)
according to international guidelines [15]. Patients
were included when at least three measurements were
available with 1-yr intervals between measurements.
Mean individual age was based on these time points.
Reference equations
The study focused on FEV1 and FVC, expressed as
% pred. Four types of reference equations were
studied. 1) A power function based on height only
described by ZAPLETAL et al. [9], expressed as % pred
Z. This was developed using data from 173 subjects
aged 6–18 yrs. 2) Linear equations by KNUDSON et al.
[8] describing a linear relationship between lung
function and height until the age of 12 yrs, and a
linear relationship with age and height for the range
of 12–17 yrs of age, expressed as % pred K. These
were based on a study of 407 healthy subjects aged
6–25 yrs. 3) A more complex power model including
age-height interaction by QUANJER et al. [4], expressed
as % pred Q. This was developed using six datasets
consisting of ventilatory function data from a total of
5,861 subjects in the age range of 6–21 yrs. 4) A set
of age-specific power equations that were based on
height only by WANG et al. [6], expressed as % pred W.
These were based on a study in 11,630 healthy subjects
aged 6–18 yrs.
The latter two reference equations [4, 6] were
especially designed to correct, as much as possible,
for the effects of the pubertal growth spurt on ven-
tilatory function in adolescents.
Data analyses
FEV1 and FVC expressed as % pred Z, % pred Q,
% pred K and % pred W were compared within
individuals using paired t-tests. Linear regression
against age was used to calculate annual individual
change of FEV1 and FVC (expressed as % pred). No
correction for slope variance or number of measure-
ments was applied, as the focus of the study was not to
determine the exact slope of lung function over time,
but to assess the within-subject differences depending
on the four equations used. Individual slopes were
compared using paired t-tests. The age dependency
of % pred Z, % pred Q, % pred K, and % pred W
was studied using correlation coefficients of indivi-
dual slopes against mean individual ages using linear
regression.
Results
In 52 patients (23 females) three or more con-
secutive annual measurements were obtained. The age
ranges for males and females at the start and end of
the study were 5.8–16.4 and 8.8–19.5 yrs, respectively.
Anthropometric and lung-function parameters at the
start and end of the analyses are shown in table 1.
FVC values at the start and at the end of the study
were similar for % pred Z and % pred K, while mean
% pred Q was lower (pv0.001) and % pred W was
higher than the other values (pv0.001). At the start
and at the end of the study FEV1 was highest when
expressed as % pred K, lower when expressed as %
pred Z or % pred W, and lowest when expressed as %
pred Q (pv0.001).
The mean annual change of FVC and FEV1 varied
according to the reference equation used (table 2).
When analysed for those children presumably at the
start of, or in the pubertal growth spurt (subgroup
Table 1. – Anthropometric and lung function data for 52
cystic fibrosis patients at the start and end of the study
Start End
Height cm 140.1¡12.6 157.4¡13.5
Age yrs 10.3¡2.2 13.8¡2.5
Weight kg 32.9¡8.3 45.9¡11.7
FVC % pred Z 96.3¡16.2 94.2¡14.7
FVC % pred K 96.0¡16.1 93.9¡14.4
FVC % pred Q 93.6¡14.3 90.2¡13.6
FVC % pred W 98.5¡15.1 96.5¡13.9
FEV1 % pred Z 89.6¡20.2 83.2¡16.8
FEV1 % pred K 94.2¡19.5 104.1¡21.2
FEV1 % pred Q 84.8¡18.1 77.7¡15.7
FEV1 % pred W 88.7¡18.9 81.6¡16.6
Data are presented as mean¡SD. FVC: forced vital capacity;
FEV1: forced expiratory volume in one second; Z: using ref-
erence equation described in ZAPLETAL et al. [9]; K: using
reference equation described in KNUDSON et al. [8]; Q:
using reference equation described in QUANJER et al. [4]; W:
using reference equation described in WANG et al. [6].
Table 2. – Annual change of forced expiratory volume in
one second (FEV1) and forced vital capacity (FVC) in 52
cystic fibrosis patients
FEV1 FVC
% pred Z -2.0¡3.8 -0.8¡3.1
% pred K 2.2¡6.2 -0.8¡3.2
% pred Q -2.1¡3.4 -1.0¡2.8
% pred W -2.2¡3.6 -0.7¡3.1
Data are presented as mean¡SD unless otherwise stated.
Z: using reference equation described in ZAPLETAL et al. [9];
K: using reference equation described in KNUDSON et al. [8];
Q: using reference equation described in QUANJER et al. [4];
W: using reference equation described in WANG et al. [6].
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with age w11 yrs, n=35), these differences became
more pronounced (table 3). Mean annual change of
FEV1 was positive, especially in the subgroup aged
w11 yrs, when expressed as % pred K. There was a
curvilinear relationship between mean age and annual
change of % pred K, with peak values around 12 yrs
(fig. 1). On average, annual change of FEV1 % pred K
increased with mean age (table 4). The differences
between FEV1 % pred K and FEV1 % pred Q were
highly variable and had their maximal valuey12 yrs
(fig. 2).
Mean annual changes of FEV1 expressed as % pred
Z, % pred Q and % pred W were negative and of
similar magnitude, but there was a significant age-
dependency of these slopes for % pred Z but not for %
pred Q or % pred W (table 4). Hence, the difference
between FEV1 % pred Q and FEV1 % pred Z varied
with age (fig. 2). Annual changes of % pred Q and %
pred W did not differ significantly, and no age
dependency could be demonstrated for either values
of FEV1 and FVC (fig. 2, table 4). As an example, the
FEV1 data of one teenage male with CF, homozygous
for DF508, was expressed according to four reference
equations and is shown in figure 3.
Discussion
A mathematical exercise was carried out by
comparing how four ventilatory function reference
equations affected the estimate of the development
of FVC and FEV1 in young patients with CF. The
conclusions are quite worrisome and confirm the
hypothesis that the choice of reference equation would
affect the estimate of lung-function development to
an important degree. This study demonstrates, that a
difference in the mathematical model of the equation
directly affects the value and, more importantly, the
estimated annual change of FVC and FEV1 in these
patients with chronic lung disease.
The biological relationship between standing height
and ventilatory function during puberty appears to
be difficult, if not impossible, to describe accurately.
Ideally, not only age but also pubertal stages should
be included in the predictions, but this is not a prac-
tical option. To the best of the authors9 knowledge,
the only attempts to correct lung function appro-
priately for the pubertal growth spurt are the reported
equations by QUANJER et al. [4] and by WANG et al. [6].
The equations by KNUDSON et al. [8] describing FVC
or FEV1 as a linear function of height until the age of
12 yrs, and as a linear function of height and age from
12 yrs resulted in a significant mean increase of
Table 3. – Change of forced expiratory volume in one
second (FEV1) and forced vital capacity (FVC) during the
study in a subgroup of 35 children aged o11 yrs
FEV1 FVC
% pred Z -1.8¡3.5 -0.4¡3.0
% pred K 3.5¡6.3 -0.6¡3.2
% pred Q -2.4¡3.2 -1.2¡2.7
% pred W -2.5¡3.3 -0.6¡3.1
Data are presented as mean¡SD unless otherwise stated.
Z: using reference equation described in ZAPLETAL et al. [9];
K: using reference equation described in KNUDSON et al. [8];
Q: using reference equation described in QUANJER et al. [4];
W: using reference equation described in WANG et al. [6].
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Fig. 1. –Relationship between mean individual age and individual
annual change of forced expiratory volume in one second (FEV1)
of 52 cystic fibrosis patients, expressed as % pred for four
reference equations. a) ZAPLETAL et al. [9] (r=0.4, pv0.01), b)
KNUDSON et al. [8] (r=0.3, pw0.05), c) QUANJER et al. [4]
(r=0.09, nonsignificant (NS)) and d) WANG et al. [6] (r=0.09, NS).
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FEV1 of y2% pred?yr-1, and this was positively
correlated with mean age. It seems highly unlikely
that normalized airway calibre would improve with
age in these CF patients because of the progressive
lung-function impairment inherent to the chronic
disease. It seems more likely that artifacts play a role,
due to the limitations of most reference equations, as
described earlier. The variable pattern of % pred K
with age, with a peak near 12 yrs may be due to the
subdivision of this reference population in one group
of children younger and one older than 12 yrs. When
FEV1 and FVC were expressed as a power function
for height [9], annual changes of FEV1 and FVC were
negative, as would be expected in CF, but were still
positively correlated with age. Again, this is unlikely
to be due to real improvement of lung disease and may
still indicate that ventilatory function is underesti-
mated during the pubertal growth spurt, and over-
estimated after or near the end of puberty. Thus, the
hypothesized artifactual under and overestimation of
lung function even plays a role in adolescents with CF,
despite the fact that their pubertal growth spurt is
delayed and less pronounced [13, 14].
When reference equations, which were designed
especially to limit "pubertal artifacts" [4, 6], were used
mean annual changes of FEV1 and FVC (% pred Q
and % pred W) were somewhat more negative com-
pared to the other two equations, and this annual
change was independent of age. This is not proof that
these reference equations reflect reality better, but it
suggests that the age-dependent artifacts are mini-
mized. These findings are consistent with the study of
ROSENFELD et al. [7]. The main difference between this
study and that of ROSENFELD et al. [7] is that this study
also compared reference equations based on American
and European children and adolescents. The present
study demonstrates that the mean annual changes
of FEV1 and FVC and their variance were similar
for % pred Q and % pred W, and that the reference
equations by QUANJER et al. [4] and WANG et al. [6]
only differed with respect to the absolute values.
The values of FEV1 and FVC, expressed as % pred W
were systematically higher than when expressed as %
pred Q. The authors speculate that this may have a
biological background. These reference equations are
based on very large populations from the USA and
from Europe that have no overlap. The conclusion
may be that on average, the European population of
children have larger lungs and airways for a given
standing height, sex and age than the American
children. Whether body proportions, especially leg
length, are really different in these two populations
remains to be investigated. Obviously, systematic
differences are of less concern than age-dependent
artifacts.
The comparisons were made with two "conven-
tional" reference equations [8, 9] because these were
based on completely different mathematical models,
and because both have been used in large studies to
describe patients with asthma [10] and with CF [11, 12].
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Fig. 2. –Within-subject differences of individual annual changes
of forced expiratory volume in one second (FEV1) in 52 cystic
fibrosis patients, according to reference equations used. a) Com-
parison of % pred Q and % pred K, b) % pred Q and % pred Z
(r=0.98, pv0.001), c) % pred Q and % pred W. Z: using reference
equation described in [9]; K: using reference equation described
in [8]; Q: using reference equation described in [4]; W: using
reference equation described in [6].
Table 4. – Correlation coefficients (r) and significant levels
(p) between mean individual ages and annual individual
changes of forced expiratory volume in one second (FEV1)
or forced vital capacity (FVC) in 52 cystic fibrosis patients
Change of FEV1 Change of FVC
r p r p
% pred Z 0.40 0.003 0.31 0.03
% pred K 0.30 0.03 0.05 NS
% pred Q 0.09 NS 0.11 NS
% pred W 0.09 NS 0.19 NS
Z: using reference equation described in ZAPLETAL et al. [9];
K: using reference equation described in KNUDSON et al. [8];
Q: using reference equation described in QUANJER et al. [4];
W: using reference equation described in WANG et al. [6];
NS: nonsignificant.
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It seems likely that other reference equations based on
similar models, would have compared likewise.
This study focused on CF patients because they are
a paediatric population in which reliable estimation
of decline of function is an important clinical and
research end-point, and the hypothesis was that even
in this group the "pubertal artifacts" would play an
important role. It is expected that these findings can
be extrapolated to other respiratory disorders, because
by studying differences between reference equations
within subjects, the results of the evaluation are
essentially independent of disease. Furthermore, in
adolescents without severe chronic disease a more pro-
nounced growth spurt can be expected, which implies
that the pubertal artifacts described earlier will be
even larger than in the patients with CF.
The implications of these findings are important for
patient care and for clinical research. For routine
follow-up of patients, one should realize that FEV1
(mL) may be the most robust test of airway function,
but apparently, longitudinal comparisons within
growing individuals are quite difficult to interpret
because correction for somatic and/or lung growth
is inadequate. Hence, longitudinal reliability of
FEV1 (% pred) is not necessarily robust. Due to the
"pubertal artifacts", most reference equations will tend
to mask true deterioration, or inflate true improve-
ment of FEV1 and FVC near the end of the growth
spurt. As a result, discrepancies may develop between
lung function (% pred) and the clinical condition in
children and adolescents with respiratory disease.
These discrepancies should be taken into account
when quality of care is assessed from estimated change
of FEV1 (% pred) as occurs for patients with CF,
and when results of different centres are compared.
Figure 3 shows the longitudinal development of FEV1
(% pred) of one patient according to four reference
equations. This example illustrates that annual indi-
vidual change of FEV1 (% pred) may vary between
2 and -3.8 % pred. Hence, the choice of reference
equation for FEV1 is likely to have a direct impact on
the management of individual patients.
For scientific purposes these findings imply that
interstudy comparisons are only reliable when no dif-
ferences exist between mean age of the populations,
and when the same reference equations are used. Even
then, annual change of function can still be artificially
age-dependent. Therefore, meta-analyses of longitu-
dinal lung-function studies in children and adolescents
should be performed preferably on raw data, using
good quality reference equations. In randomized
trials, differences in mean age between subgroups
may affect outcome. This effect should be minimal
after stratification for age. In long-term crossover
trials the artifacts may lead to carry-over effects.
Guidelines for choosing appropriate reference
equations have been published [3], but there have
been no consensus reports recommending specific
reference equations. The conclusions of the present
study imply that age and height are needed as inde-
pendent variables to improve the quality of paediatric
pulmonary reference equations, and that updating
these equations is probably necessary because of
cohort effects in the age-height relationship in children
and adolescents. The suggestion is that large inter-
national bodies such as the American Thoracic
Society and the European Respiratory Society
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Fig. 3. – Illustration of individual trends for forced expiratory
volume in one second (FEV1), according to four reference equa-
tions in a teenage male with cystic fibrosis. a) [9] (-2.0% pred?yr-1),
b) [8] (2.0% pred?yr-1), c) [4] (-2.6% pred?yr-1) and d) [6] (-3.8%
pred?yr-1).
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should recommend, and regularly update, specific
reference equations to be used for older children and
adolescents or develop them, based on large data-
bases. The reference equations for forced expiratory
volume in one second and forced vital capacity
developed by QUANJER et al. [4] and those by WANG
et al.[5] may be a suitable starting point.
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